TOIbenzinga

The Oncology Institute Q4 2024 EPS $(0.14) Comapred to $(0.21) YoY, Sales $100.27M Vs. $85.79M YoY

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 24, 2025 by benzinga